» Authors » Ken Shiraishi

Ken Shiraishi

Explore the profile of Ken Shiraishi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 49
Citations 271
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Yatsuzuka K, Yoshida S, Miura N, Kohri N, Muto J, Shiraishi K, et al.
J Dermatol . 2024 Dec; 52(2):e147-e148. PMID: 39663870
No abstract available.
2.
Yatsuzuka K, Muto J, Kohri N, Yoshida S, Shiraishi K, Fujisawa Y
Int J Dermatol . 2024 Oct; 64(3):582-583. PMID: 39400316
No abstract available.
3.
Dai X, Mizukami Y, Watanabe K, Tsuda T, Shidahara M, Yoshida S, et al.
J Invest Dermatol . 2024 Oct; PMID: 39384017
Skin barrier dysfunction initiates or deteriorates various cutaneous problems, such as atopic dermatitis. At high concentrations, the nonreducing disaccharide trehalose (α-d-glucopyranosyl α-d-glucopyranoside) induces a transient senescence-like state in fibroblasts and...
4.
Yatsuzuka K, Muto J, Shiraishi K, Fujisawa Y, Murakami M
Cureus . 2024 Aug; 16(7):e64680. PMID: 39149635
Although rare, paradoxical eczema (PE) is an adverse event associated with the use of biological agents to treat psoriasis, particularly in patients with atopic predispositions. We report the first case...
5.
Shiraishi K, Miyazaki Y, Kohri N, Yoshida S, Yatsuzuka K, Muto J, et al.
Eur J Dermatol . 2024 Jul; 34(3):298-300. PMID: 39015965
No abstract available.
6.
Yoshida S, Shiraishi K, Yatsuzuka K, Kohri N, Muto J, Murakami M, et al.
Eur J Dermatol . 2024 Jul; 34(3):271-275. PMID: 39015961
Cholinergic urticaria with hypohidrosis or anhidrosis (CUHA) can impair quality of life due to itching, tingling, and reduced sweating. Current treatment options for CUHA include antihistamines, pulsed steroids, and sweat-promoting...
7.
Yatsuzuka K, Muto J, Shiraishi K, Murakami M, Fujisawa Y
Cureus . 2024 Jul; 16(6):e61567. PMID: 38962596
Psoriasis vulgaris, also known as plaque-type psoriasis, is the most common form of psoriasis. It is characterized by erythematous plaques covered with scales. Among the available treatments, the fully human...
8.
Yatsuzuka K, Kawakami R, Niko Y, Tsuda T, Kameda K, Kohri N, et al.
Sci Rep . 2024 Jan; 14(1):378. PMID: 38172327
Sweat is an essential protection system for the body, but its failure can result in pathologic conditions, including several skin diseases, such as palmoplantar pustulosis (PPP). As reduced intraepidermal E-cadherin...
9.
Hayashi M, Shiraishi K, Yoshida S, Yatsuzuka K, Kohri N, Kuroo Y, et al.
J Dermatol . 2023 Dec; 51(5):e166-e167. PMID: 38063285
No abstract available.
10.
Shiraishi K, Sayama K
Ann Dermatol . 2023 Dec; 35(Suppl 2):S345-S346. PMID: 38061738
No abstract available.